India has increased its efforts to expose its traditional medicine systems to worldwide scientific scrutiny, as fresh facts revealed in Parliament indicate how AYUSH-based research is being presented at international venues to boost legitimacy, safety, and public confidence. 

On December 12, 2025, Minister of State for AYUSH Prataprao Jadhav responded to a starred question in the Lok Sabha, describing how the government is using worldwide platforms to position Ayurveda, yoga, Unani, Siddha, and homoeopathy inside mainstream healthcare discussions. The effort comes as millions of people around the world practise traditional medicine, sometimes without clear standards or shared evidence. 

The Promotion of International Cooperation in the AYUSH plan, a central sector programme aimed at expanding Indian research outside national lines, is at the heart of this policy. According to the official statement, the initiative benefits AYUSH drug producers and service providers, increases exports, and fosters intellectual interaction by establishing AYUSH chairs in foreign universities and financing international conferences and research collaborations. 

The primary goal of presenting AYUSH-based clinical data globally is to transform traditional medicine from belief to proof. By exchanging research data, treatment outcomes, and safety information, India hopes to demonstrate how these systems may complement rather than compete with current medicine. Simply put, the government wants existing treatments to be tested, classed, and tracked in the same transparent manner as other healthcare interventions. 

India's participation with the World Health Organisation is a significant milestone in this effort. An agreement with WHO resulted in the construction of the WHO Global Traditional Medicine Centre in Jamnagar, Gujarat. The centre serves as a global information hub, assisting countries in building legislation, standards, and data systems for traditional medicine. Its claimed goals include guaranteeing quality, safety, and efficacy, defining international rules, and establishing shared databases and training programmes. 

India also collaborated with WHO on practical instruments. In 2022, benchmark documents for training and practice in Ayurveda and Unani were published, as well as standardised terminology for Ayurveda, Unani, and Siddha. In May 2025, another agreement was struck to create traditional medicine intervention categories for the International Classification of Health Interventions. This phase is significant because it enables traditional therapies to be recorded, compared, and evaluated using a common global health language. 

In addition to WHO, the ministry has inked 25 country-to-country agreements and dozens of institutional partnerships to promote research and academic exchange. These include AYUSH academic chairs, information centres overseas, and scholarships for international students studying in India. 

Bengaluru is also represented in this worldwide outreach. The Central Council for Research in Ayurvedic Sciences, the ministry's top research organisation, has a Central Ayurveda Research Institute in the city. This institute participates in collaborative projects that help connect Indian clinical research to worldwide expectations. 

Patients' overall goal is safety and clarity. By bringing AYUSH research to global forums, India hopes to ensure that traditional medicine is regulated, evidence-based, and in line with universal health care, rather than being informal or unverified.